[SCHEDULE 13G/A] NeuroMetrix, Inc. SEC Filing

Rhea-AI Filing Summary

NeuroMetrix, Inc. Schedule 13G/A (Amendment No. 2) discloses that The Radoff Family Foundation and Bradley L. Radoff no longer beneficially own any common stock of the company. As of the close of business on June 30, 2025, both Reporting Persons report 0 shares and 0% ownership of the class, indicating they hold no voting or dispositive power over NeuroMetrix shares.

The filing identifies the reporting entities, their principal address and citizenship, confirms the disclosure covers common stock with $0.0001 par value, and includes a certification that the securities were not acquired to influence control of the issuer.

Positive

• Clear disclosure: Reporting Persons explicitly state they own 0 shares as of June 30, 2025.
• Amendment filed: This is an Amendment No. 2 Schedule 13G/A, updating prior disclosures and maintaining regulatory transparency.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine disclosure; Reporting Persons now hold zero shares of NURO, removing them from ownership schedules.

The amendment clarifies ownership status: both The Radoff Family Foundation and Bradley L. Radoff report 0 shares (0%) as of June 30, 2025. For investors, this is a neutral, procedural update that removes these Reporting Persons from the register of beneficial holders. There are no indications of purchases, sales, or changes in control intent disclosed in the statement; the filing includes the standard certification regarding non-interference with issuer control.

Corporate Governance Expert

TL;DR: Corporate governance impact is minimal; disclosure improves transparency but shows no ongoing stake.

The Schedule 13G/A (Amendment No. 2) is a compliance filing that documents the cessation of beneficial ownership by the named reporting parties. The declaration of 0 shares and the certification language indicate the Reporting Persons are not participants in control-related transactions. This reduces any governance-related scrutiny tied to these specific parties but does not otherwise alter the companys board composition or shareholder profile as described in the filing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

NeuroMetrix, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

641255880

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 641255880

1

Names of Reporting Persons

Radoff Family Foundation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

TEXAS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 641255880

1

Names of Reporting Persons

Radoff Bradley Louis

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: NeuroMetrix, Inc.
(b)	Address of issuer's principal executive offices: 4B Gill Street, Woburn, Massachusetts 01801
Item 2.
(a)	Name of person filing: This statement is filed by The Radoff Family Foundation, a Texas non-profit corporation ("Radoff Foundation"), and Bradley L. Radoff. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
(b)	Address or principal business office or, if none, residence: The address of the principal office of each of the Reporting Persons is 2727 Kirby Drive, Unit 29L, Houston, Texas 77098.
(c)	Citizenship: Radoff Foundation is organized under the laws of the State of Texas and Mr. Radoff is a citizen of the United States of America.
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 641255880
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2025, the Reporting Persons no longer beneficially owned any securities of the Issuer.
(b)	Percent of class: As of the close of business on June 30, 2025, the Reporting Persons no longer beneficially owned any securities of the Issuer.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on September 27, 2024.
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Radoff Family Foundation

Signature:	/s/ Bradley L. Radoff
Name/Title:	Bradley L. Radoff, Director
Date:	08/13/2025

Radoff Bradley Louis

Signature:	/s/ Bradley L. Radoff
Name/Title:	Bradley L. Radoff
Date:	08/13/2025

FAQ

Who filed the Schedule 13G/A for NeuroMetrix (NURO)?

The filing was submitted by The Radoff Family Foundation (a Texas non-profit) and Bradley L. Radoff as the Reporting Persons.

Do the Radoff reporting persons currently own NURO shares?

No. As of the close of business on June 30, 2025, both Reporting Persons reported owning 0 shares, representing 0% of the class.

What class of securities is covered by this filing for NURO?

The filing covers Common Stock of NeuroMetrix, Inc., with a par value of $0.0001 per share.

Does the filing indicate any intent to influence control of the issuer?

The certification in Item 10 states the securities were not acquired and are not held for the purpose of changing or influencing control and were not acquired in connection with such transactions.

What is the effect of this amendment on investor ownership records?

The amendment documents that these Reporting Persons no longer appear as beneficial owners of NURO shares, which updates ownership records to reflect their 0% stake.